.With a strong record for identifying rough diamonds, Bain Funds Daily Life Sciences (BCLS) has ende...
.The recent choice to merge Genentech's 2 cancer cells teams was actually made for "clinical factors...
.Terns Pharmaceuticals' choice to lose its liver illness aspirations may however pay off, after the ...
.Merck & Co.'s long-running attempt to land a punch on tiny tissue lung cancer cells (SCLC) has a...
.Some patients along with non-small tissue lung cancer cells (NSCLC) have mutations in a genetics na...
.MBX has actually expanded programs to enjoy over $136 thousand from its IPO as the biotech hopes to...
.Relay Therapeutics has actually beaten its own survival goal in a first-in-human bust cancer study,...
.AstraZeneca has used expert system to devise an one-of-a-kind biomarker for its Daiichi Sankyo-part...
.AstraZeneca execs say they are "certainly not worried" that the breakdown of tozorakimab in a stage...
.Invite to this week's Chutes & Ladders, our summary of notable leadership hirings, shootings and...